Cargando…
Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
BACKGROUND: Pancreatic carcinoma possesses one of the highest lethality rates, highest drug-resistance, and highest incidence rates. The objective of this research was to enhance the efficacy and drug-resistance for pancreatic carcinoma by using inhibition of SIRT1 combined with gemcitabine therapy...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718766/ https://www.ncbi.nlm.nih.gov/pubmed/23898224 http://dx.doi.org/10.2147/CIA.S45064 |